Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Scheidegger NK"'
Autor:
Larrue C; Translational Research Center for Hemato-Oncology, Faculty of Medicine, University of Geneva, Geneva, Switzerland. clement.larrue@inserm.fr.; Swiss Cancer Center Leman, Lausanne, Switzerland. clement.larrue@inserm.fr., Mouche S; Translational Research Center for Hemato-Oncology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.; Swiss Cancer Center Leman, Lausanne, Switzerland., Lin S; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA, USA.; The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Simonetta F; Translational Research Center for Hemato-Oncology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.; Swiss Cancer Center Leman, Lausanne, Switzerland., Scheidegger NK; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA, USA.; The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Poulain L; Translational Research Center for Hemato-Oncology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.; Swiss Cancer Center Leman, Lausanne, Switzerland., Birsen R; Translational Research Center for Hemato-Oncology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.; Swiss Cancer Center Leman, Lausanne, Switzerland., Sarry JE; Cancer Research Centre of Toulouse, UMR1037 Inserm, UMR5077 CNRS, Université de Toulouse 3 Paul Sabatier, Equipe Labellisée LIGUE 2018, 31037, Toulouse, France., Stegmaier K; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA, USA.; The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Tamburini J; Translational Research Center for Hemato-Oncology, Faculty of Medicine, University of Geneva, Geneva, Switzerland. jerome.tamburinibonnefoy@unige.ch.; Swiss Cancer Center Leman, Lausanne, Switzerland. jerome.tamburinibonnefoy@unige.ch.
Publikováno v:
Leukemia [Leukemia] 2023 Apr; Vol. 37 (4), pp. 765-775. Date of Electronic Publication: 2023 Feb 04.
Autor:
Lin S; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, Massachusetts.; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Larrue C; Translational Research Centre in Onco-hematology, Faculty of Medicine, University of Geneva, Geneva, Switzerland., Scheidegger NK; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, Massachusetts.; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Seong BKA; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, Massachusetts.; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Dharia NV; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, Massachusetts.; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Kuljanin M; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Wechsler CS; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, Massachusetts., Kugener G; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Robichaud AL; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, Massachusetts., Conway AS; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, Massachusetts., Mashaka T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Mouche S; Translational Research Centre in Onco-hematology, Faculty of Medicine, University of Geneva, Geneva, Switzerland., Adane B; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, Massachusetts.; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Ryan JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Mancias JD; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Younger ST; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Piccioni F; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Lee LH; Division of Oncology, Cancer and Blood Disease Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio., Wunderlich M; Division of Experimental Hematology and Cancer Biology, Cancer and Blood Disease Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio., Letai A; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Tamburini J; Translational Research Centre in Onco-hematology, Faculty of Medicine, University of Geneva, Geneva, Switzerland., Stegmaier K; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, Massachusetts. Kimberly_stegmaier@dfci.harvard.edu.; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
Publikováno v:
Cancer discovery [Cancer Discov] 2022 Feb; Vol. 12 (2), pp. 432-449. Date of Electronic Publication: 2021 Sep 16.